US20230292827A1 - Nicotine pouch with capsule having mct oil - Google Patents
Nicotine pouch with capsule having mct oil Download PDFInfo
- Publication number
- US20230292827A1 US20230292827A1 US17/700,401 US202217700401A US2023292827A1 US 20230292827 A1 US20230292827 A1 US 20230292827A1 US 202217700401 A US202217700401 A US 202217700401A US 2023292827 A1 US2023292827 A1 US 2023292827A1
- Authority
- US
- United States
- Prior art keywords
- pouch
- nicotine
- gelatin capsule
- oral
- nicotine product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims abstract description 94
- 229960002715 nicotine Drugs 0.000 title claims abstract description 94
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title claims abstract description 94
- 239000002775 capsule Substances 0.000 title claims abstract description 32
- 229940057917 medium chain triglycerides Drugs 0.000 claims abstract description 54
- 239000000796 flavoring agent Substances 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- 239000003921 oil Substances 0.000 claims description 51
- 239000007903 gelatin capsule Substances 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 20
- 239000008187 granular material Substances 0.000 claims description 19
- 239000000835 fiber Substances 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- 150000003505 terpenes Chemical class 0.000 claims description 6
- 235000007586 terpenes Nutrition 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- 229920000297 Rayon Polymers 0.000 claims description 5
- 229920005822 acrylic binder Polymers 0.000 claims description 5
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 5
- 229920000728 polyester Polymers 0.000 claims description 5
- 239000002964 rayon Substances 0.000 claims description 5
- 239000004376 Sucralose Substances 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 235000019408 sucralose Nutrition 0.000 claims description 4
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 230000003444 anaesthetic effect Effects 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 239000003193 general anesthetic agent Substances 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 235000010356 sorbitol Nutrition 0.000 claims description 3
- 235000019640 taste Nutrition 0.000 claims description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 2
- 229940035674 anesthetics Drugs 0.000 claims description 2
- 241000208125 Nicotiana Species 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 238000010586 diagram Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229940005494 general anesthetics Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F23/00—Cases for tobacco, snuff, or chewing tobacco
- A24F23/02—Tobacco pouches
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
- A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
- A24B15/303—Plant extracts other than tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
- A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
- A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B3/00—Preparing tobacco in the factory
- A24B3/12—Steaming, curing, or flavouring tobacco
Definitions
- Embodiments of the present invention generally relate to the field of nicotine products. More specifically, embodiments of the present invention relate to oral nicotine products contained in small containers called pouches.
- Embodiments of the present invention provide a pouch for holding and delivering nicotine including a capsule that releases medium chain triglycerides (MCT), which are a non-stick oil agent that prevents the pouch paper from sticking during use.
- MCT medium chain triglycerides
- the oil is released from the capsule as it is crushed or dissolved, and flows through the walls of the pouch paper to substantially improve mouth feel and flavor.
- the nicotine pouch is not buffered to a high pH and offer a pleasant mouth feel during use.
- the capsule in accordance with embodiments of the present invention can also provide an anti-sting effect that reduces unpleasant effects of nicotine for sensitive users.
- an oral nicotine product includes a pouch including fiber paper, a granulate mixture including nicotine disposed within the pouch, and a gelatin capsule including medium chain triglycerides (MCT) oil disposed within the pouch, the capsule is operable to release the MCT oil when broken, and the pouch is operable to release the granulate mixture and the MCT oil over time when used orally.
- MCT medium chain triglycerides
- the MCT oil is operable to function as an anti-stick agent to substantially restrict the fiber paper of the pouch from sticking.
- the gelatin capsule further includes a natural anesthetic.
- the gelatin capsule further includes terpenes or essential oils.
- the granulate mixture further includes microcrystalline cellulose, b-cyclodextrin, a complexing agent, filler, or salt.
- the gelatin capsule further includes sorbitol, glycerin, sucralose, or coloring agents.
- the gelatin capsule is a spherical 5 mm gelatin capsule.
- the gelatin capsule further includes flavoring agents.
- the MCT oil is operable to function to reduce an unpleasant taste produced by the nicotine.
- the fiber paper includes chemically bonded rayon blended with polyester and an acrylic binder.
- an oral nicotine product including a pouch including fiber paper, a granulate mixture including nicotine disposed within the pouch, and a gelatin capsule including medium chain triglycerides (MCT) oil disposed within the pouch, and the capsule is operable to partially dissolve in contact with saliva when used orally to release the MCT oil, and the pouch is further operable to release the granulate mixture and the MCT oil over time.
- MCT medium chain triglycerides
- an oral nicotine product including a pouch including rayon with polyester and an acrylic binder, a granulate mixture disposed within the pouch, the granulated mixture includes nicotine, microcrystalline cellulose, and b-cyclodextrin, and a gelatin capsule including medium chain triglycerides (MCT) oil, essential oils, and terpenes, and natural anesthetics disposed within the pouch, the capsule releases the MCT oil over time when held in a mouth, and the pouch is operable to release the granulate mixture and the MCT oil over time into the mouth when used orally.
- MCT medium chain triglycerides
- FIG. 1 is a diagram of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention.
- FIG. 2 is a diagram of a side view of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention.
- FIG. 3 is a diagram of another side view of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention.
- FIG. 4 is a diagram of a top view of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention.
- FIG. 5 is a diagram of a bottom view of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention.
- Embodiments of the present invention provide pouches including a capsule which delivers medium chain triglycerides (MCT), which are a non-stick oil agent that prevent the pouch paper from sticking during use.
- MCT medium chain triglycerides
- the pouch with capsule are designed to be used orally, for instance, as an oral nicotine product. This oil is released from the capsule and flows through the walls of the pouch paper to substantially improve mouth feel and flavor.
- the nicotine pouch is not buffered to a high pH and offer a pleasant mouth feel during use.
- the capsule can also provide an anti-sting effect that reduces unpleasant effects of nicotine for sensitive users.
- FIG. 1 depicts an exemplary oral nicotine product (“nicotine pouch”) 105 according to embodiments of the present invention.
- Nicotine pouch 105 includes fiber paper that holds a granulate mixture of nicotine, bulking agents, flavors, and/or sweeteners.
- the pouch material as is well-known can be a chemically bonded fabric made of regenerated cellulose (e.g., rayon) that is blended with polyester and an acrylic binder. Nicotine pouch 105 can include a small amount of MCT oil to improve the mouth feel of the pouch and has a pH level appropriate for nicotine delivery (e.g., 8.0-9.1).
- the nicotine pouch 105 is placed in the mouth during use and the granulate mixture is absorbed by the user's mouth and gums through the porous walls of the fiber paper, with the MCT oil advantageously preventing sticking and improving mouth feel.
- the pouch can also be made from an any heat sealable fabric made of elastic mesh of polyamide, thermoplastic polyurethane, silicone, latex, rubber, plastic, melt blown polymer fibers, or any nonwoven fabric produced by dry-laid, wet-laid, or spun melt processes, as is well-known in the art.
- the granulate mixture includes nicotine b-cyclodextrin complex blended with microcrystalline cellulose.
- the nicotine level of the granulate mixture is between 4 mg and 20 mg of nicotine according to embodiments.
- the nicotine b-cyclodextrin granulate can be dried and mixed with microcrystalline cellulose, mannitol, maltitol, erythritol, sucralose, calcium lactate, sodium bicarbonate, flavoring agents, and can be granulated with a solution of gum arabic or HPC.
- the pouch holds nicotine derived from tobacco. According to other embodiments, the pouch holds nicotine derived synthetically. Other embodiments may hold nicotine produced by other means, or different combinations of methods.
- the nicotine pouch 105 includes a capsule 110 that is held in the mouth (e.g., along the gum line) to release flavors carried in MCT oil that both increase the flavor profile of the product and oil or “moisten” the pouch.
- capsule 110 is a spherical 5 mm gelatin capsule that releases MCT oil during use which is then coated onto the mouth and gums thereby improving flavor and mouthfeel.
- Capsule 110 can further include sorbitol, glycerin, sucralose, and coloring agents, for example.
- capsule 110 holds glycerol and mineral oil that act as non-stick agents instead of or in addition to MCT oil.
- the nicotine pouch 105 is held in the user's mouth, for example, along the gum line, and the nicotine flows through the pouch paper into the user's mouth, coating the mouth and gums.
- the active nicotine is enjoyed by the user over a period of about 20 minutes before the nicotine is fully consumed.
- Capsule 110 can be crushed in the mouth during use to rapidly release the flavors and oils held within, and nicotine pouch 105 can be held in the user's mouth for approximately 20 minutes for the nicotine to fully absorb.
- the capsule 110 can be crushed by biting, chewing, or otherwise compressing the capsule such that the walls of the capsule are punctured to release the oil held within.
- pouch 105 can be held in the mouth without breaking capsule 110 , in which case capsule 110 slowly dissolves over a period of approximately 5 to 10 minutes when in contact with saliva in the mouth, allowing the flavors and oils to release slowly over time.
- the oil e.g., MCT oil
- capsule 110 includes natural general anesthetics such as thymol, eugenol, or linalool that are released from the capsule to offset unpleasant effects or flavors of nicotine (e.g., stinging effects).
- natural general anesthetics such as thymol, eugenol, or linalool that are released from the capsule to offset unpleasant effects or flavors of nicotine (e.g., stinging effects).
- capsule 110 includes terpenes and/or essential oils that are released from the capsule and absorbed by the mouth and gums.
- FIG. 2 is a diagram of a side view of an exemplary nicotine pouch 105 and MCT oil gelatin capsule 110 according to embodiments of the present invention. From the side view, nicotine pouch 105 is oval and shape with a seam running horizontally across nicotine pouch 105 . MCT oil gelatin capsule 110 is disposed in the center of nicotine pouch 105 and is crushed or dissolved during use. The nicotine and MCT oil flow from within pouch 105 through the porous walls and into the user's mouth so that the user can enjoy the nicotine and improved mouth feel (without sticking).
- FIG. 3 is a diagram of another side view of an exemplary nicotine pouch 105 and MCT oil gelatin capsule 110 according to embodiments of the present invention.
- FIG. 4 is a diagram of a top view of an exemplary nicotine pouch 105 and MCT oil gelatin capsule 110 according to embodiments of the present invention. The seam runs along the top surface of nicotine pouch 105 and the edges of pouch 105 are sealed closed.
- FIG. 5 is a diagram of a bottom view of an exemplary nicotine pouch 105 and MCT oil gelatin capsule 110 according to embodiments of the present invention.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Embodiments of the present invention provide pouches including a capsule delivers medium chain triglycerides (MCT), which are a non-stick oil agent that prevent the paper from sticking during use. This oil is released from the capsule and flows through the walls of the pouch paper to substantially improve mouth feel and flavor. The oil can be flavored, and the nicotine pouch offers a pleasant mouth feel during use without sticking to the gums. The capsule can also provide an anti-sting effect that reduces unpleasant effects of nicotine for sensitive users.
Description
- Embodiments of the present invention generally relate to the field of nicotine products. More specifically, embodiments of the present invention relate to oral nicotine products contained in small containers called pouches.
- Traditional means of enjoying nicotine orally involve the use of materials that can become sticky and feel unpleasant in the mouth during use. Many nicotine products are available in small containers called pouches. Commonly used products in nicotine pouches such as gum arabic, microcrystalline cellulose, or hydroxypropyl cellulose (HPC) can have undesirable adhesive qualities. Accordingly, some pouches and papers for use with nicotine can stick to the user's gum line which can become uncomfortable during continued use or can make the product difficult to use because the nicotine product is unable to move smoothly through the paper. In many cases these products are also buffered to a high pH for nicotine absorption using sodium carbonate or sodium bicarbonate, and constant exposure to basic substances in the mouth can wear away tooth enamel and cause serious damage to teeth and gums. Improved nicotine pouches are desired.
- Accordingly, what is needed is a nicotine pouch that is not buffered to a high pH and offers a pleasant mouth feel during use. Embodiments of the present invention provide a pouch for holding and delivering nicotine including a capsule that releases medium chain triglycerides (MCT), which are a non-stick oil agent that prevents the pouch paper from sticking during use. The oil is released from the capsule as it is crushed or dissolved, and flows through the walls of the pouch paper to substantially improve mouth feel and flavor. The nicotine pouch is not buffered to a high pH and offer a pleasant mouth feel during use. The capsule in accordance with embodiments of the present invention can also provide an anti-sting effect that reduces unpleasant effects of nicotine for sensitive users.
- According to one embodiment, an oral nicotine product is disclosed. The oral nicotine product includes a pouch including fiber paper, a granulate mixture including nicotine disposed within the pouch, and a gelatin capsule including medium chain triglycerides (MCT) oil disposed within the pouch, the capsule is operable to release the MCT oil when broken, and the pouch is operable to release the granulate mixture and the MCT oil over time when used orally.
- According to some embodiments, the MCT oil is operable to function as an anti-stick agent to substantially restrict the fiber paper of the pouch from sticking.
- According to some embodiments, the gelatin capsule further includes a natural anesthetic.
- According to some embodiments, the gelatin capsule further includes terpenes or essential oils.
- According to some embodiments, the granulate mixture further includes microcrystalline cellulose, b-cyclodextrin, a complexing agent, filler, or salt.
- According to some embodiments, the gelatin capsule further includes sorbitol, glycerin, sucralose, or coloring agents.
- According to some embodiments, the gelatin capsule is a spherical 5 mm gelatin capsule.
- According to some embodiments, the gelatin capsule further includes flavoring agents.
- According to some embodiments, the MCT oil is operable to function to reduce an unpleasant taste produced by the nicotine.
- According to some embodiments, the fiber paper includes chemically bonded rayon blended with polyester and an acrylic binder.
- According to another embodiment, an oral nicotine product is disclosed, including a pouch including fiber paper, a granulate mixture including nicotine disposed within the pouch, and a gelatin capsule including medium chain triglycerides (MCT) oil disposed within the pouch, and the capsule is operable to partially dissolve in contact with saliva when used orally to release the MCT oil, and the pouch is further operable to release the granulate mixture and the MCT oil over time.
- According to a different embodiment, an oral nicotine product is disclosed, including a pouch including rayon with polyester and an acrylic binder, a granulate mixture disposed within the pouch, the granulated mixture includes nicotine, microcrystalline cellulose, and b-cyclodextrin, and a gelatin capsule including medium chain triglycerides (MCT) oil, essential oils, and terpenes, and natural anesthetics disposed within the pouch, the capsule releases the MCT oil over time when held in a mouth, and the pouch is operable to release the granulate mixture and the MCT oil over time into the mouth when used orally.
- The accompanying drawings, which are incorporated in and form a part of this specification and in which like numerals depict like elements, illustrate embodiments of the present disclosure and, together with the description, serve to explain the principles of the disclosure.
-
FIG. 1 is a diagram of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention. -
FIG. 2 is a diagram of a side view of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention. -
FIG. 3 is a diagram of another side view of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention. -
FIG. 4 is a diagram of a top view of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention. -
FIG. 5 is a diagram of a bottom view of an exemplary product containing a nicotine pouch and MCT oil gelatin capsule according to embodiments of the present invention. - Reference will now be made in detail to several embodiments. While the subject matter will be described in conjunction with the alternative embodiments, it will be understood that they are not intended to limit the claimed subject matter to these embodiments. On the contrary, the claimed subject matter is intended to cover alternative, modifications, and equivalents, which may be included within the spirit and scope of the claimed subject matter as defined by the appended claims.
- Furthermore, in the following detailed description, numerous specific details are set forth in order to provide a thorough understanding of the claimed subject matter. However, it will be recognized by one skilled in the art that embodiments may be practiced without these specific details or with equivalents thereof. In other instances, well-known methods, procedures, components, and circuits have not been described in detail as not to unnecessarily obscure aspects and features of the subject matter. It should be borne in mind, however, that all of these and similar terms are to be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities.
- Embodiments of the present invention provide pouches including a capsule which delivers medium chain triglycerides (MCT), which are a non-stick oil agent that prevent the pouch paper from sticking during use. The pouch with capsule are designed to be used orally, for instance, as an oral nicotine product. This oil is released from the capsule and flows through the walls of the pouch paper to substantially improve mouth feel and flavor. The nicotine pouch is not buffered to a high pH and offer a pleasant mouth feel during use. The capsule can also provide an anti-sting effect that reduces unpleasant effects of nicotine for sensitive users.
-
FIG. 1 depicts an exemplary oral nicotine product (“nicotine pouch”) 105 according to embodiments of the present invention.Nicotine pouch 105 includes fiber paper that holds a granulate mixture of nicotine, bulking agents, flavors, and/or sweeteners. The pouch material as is well-known can be a chemically bonded fabric made of regenerated cellulose (e.g., rayon) that is blended with polyester and an acrylic binder.Nicotine pouch 105 can include a small amount of MCT oil to improve the mouth feel of the pouch and has a pH level appropriate for nicotine delivery (e.g., 8.0-9.1). In accordance with various embodiments, thenicotine pouch 105 is placed in the mouth during use and the granulate mixture is absorbed by the user's mouth and gums through the porous walls of the fiber paper, with the MCT oil advantageously preventing sticking and improving mouth feel. The pouch can also be made from an any heat sealable fabric made of elastic mesh of polyamide, thermoplastic polyurethane, silicone, latex, rubber, plastic, melt blown polymer fibers, or any nonwoven fabric produced by dry-laid, wet-laid, or spun melt processes, as is well-known in the art. - According to some embodiments, the granulate mixture includes nicotine b-cyclodextrin complex blended with microcrystalline cellulose. The nicotine level of the granulate mixture is between 4 mg and 20 mg of nicotine according to embodiments. The nicotine b-cyclodextrin granulate can be dried and mixed with microcrystalline cellulose, mannitol, maltitol, erythritol, sucralose, calcium lactate, sodium bicarbonate, flavoring agents, and can be granulated with a solution of gum arabic or HPC.
- According to some embodiments, the pouch holds nicotine derived from tobacco. According to other embodiments, the pouch holds nicotine derived synthetically. Other embodiments may hold nicotine produced by other means, or different combinations of methods.
- Advantageously, the
nicotine pouch 105 includes acapsule 110 that is held in the mouth (e.g., along the gum line) to release flavors carried in MCT oil that both increase the flavor profile of the product and oil or “moisten” the pouch. In the example ofFIG. 1 ,capsule 110 is a spherical 5 mm gelatin capsule that releases MCT oil during use which is then coated onto the mouth and gums thereby improving flavor and mouthfeel. Capsule 110 can further include sorbitol, glycerin, sucralose, and coloring agents, for example. In alternative embodiments,capsule 110 holds glycerol and mineral oil that act as non-stick agents instead of or in addition to MCT oil. - The
nicotine pouch 105 is held in the user's mouth, for example, along the gum line, and the nicotine flows through the pouch paper into the user's mouth, coating the mouth and gums. The active nicotine is enjoyed by the user over a period of about 20 minutes before the nicotine is fully consumed.Capsule 110 can be crushed in the mouth during use to rapidly release the flavors and oils held within, andnicotine pouch 105 can be held in the user's mouth for approximately 20 minutes for the nicotine to fully absorb. Thecapsule 110 can be crushed by biting, chewing, or otherwise compressing the capsule such that the walls of the capsule are punctured to release the oil held within. Alternatively,pouch 105 can be held in the mouth without breakingcapsule 110, in whichcase capsule 110 slowly dissolves over a period of approximately 5 to 10 minutes when in contact with saliva in the mouth, allowing the flavors and oils to release slowly over time. The oil (e.g., MCT oil) flows easily through the walls ofnicotine pouch 105 during use and prevents unwanted sticking to the gum line. - According to some embodiments,
capsule 110 includes natural general anesthetics such as thymol, eugenol, or linalool that are released from the capsule to offset unpleasant effects or flavors of nicotine (e.g., stinging effects). - According to some embodiments,
capsule 110 includes terpenes and/or essential oils that are released from the capsule and absorbed by the mouth and gums. -
FIG. 2 is a diagram of a side view of anexemplary nicotine pouch 105 and MCToil gelatin capsule 110 according to embodiments of the present invention. From the side view,nicotine pouch 105 is oval and shape with a seam running horizontally acrossnicotine pouch 105. MCToil gelatin capsule 110 is disposed in the center ofnicotine pouch 105 and is crushed or dissolved during use. The nicotine and MCT oil flow from withinpouch 105 through the porous walls and into the user's mouth so that the user can enjoy the nicotine and improved mouth feel (without sticking).FIG. 3 is a diagram of another side view of anexemplary nicotine pouch 105 and MCToil gelatin capsule 110 according to embodiments of the present invention. -
FIG. 4 is a diagram of a top view of anexemplary nicotine pouch 105 and MCToil gelatin capsule 110 according to embodiments of the present invention. The seam runs along the top surface ofnicotine pouch 105 and the edges ofpouch 105 are sealed closed.FIG. 5 is a diagram of a bottom view of anexemplary nicotine pouch 105 and MCToil gelatin capsule 110 according to embodiments of the present invention. - Embodiments of the present invention are thus described. While the present invention has been described in particular embodiments, it should be appreciated that the present invention should not be construed as limited by such embodiments, but rather construed according to the following claims.
Claims (20)
1. An oral nicotine product, comprising:
a pouch comprising fiber paper;
a granulate mixture comprising nicotine disposed within the pouch; and
a gelatin capsule comprising medium chain triglycerides (MCT) oil disposed within the pouch, wherein the capsule is operable to release the MCT oil when broken, and wherein the pouch is operable to release the granulate mixture and the MCT oil over time when used orally.
2. The oral nicotine product of claim 1 , wherein the MCT oil is operable to function as an anti-stick agent to substantially restrict the fiber paper of the pouch from sticking to gums when used orally.
3. The oral nicotine product of claim 1 , wherein the gelatin capsule further comprises a natural anesthetic.
4. The oral nicotine product of claim 1 , wherein the gelatin capsule further comprises terpenes or essential oils.
5. The oral nicotine product of claim 1 , wherein the granulate mixture comprises 4 to 20 mg of nicotine.
6. The oral nicotine product of claim 1 , wherein the gelatin capsule further comprises sorbitol, glycerin, sucralose, or coloring agents.
7. The oral nicotine product of claim 1 , wherein the gelatin capsule is a spherical 5 mm gelatin capsule.
8. The oral nicotine product of claim 1 , wherein the gelatin capsule further comprises flavoring agents.
9. The oral nicotine product of claim 1 , wherein the MCT oil is operable to function to reduce an unpleasant taste produced by the nicotine.
10. The oral nicotine product of claim 1 , wherein the fiber paper comprises chemically bonded rayon blended with polyester and an acrylic binder.
11. An oral nicotine product, comprising:
a pouch comprising fiber paper;
a granulate mixture comprising nicotine disposed within the pouch; and
a gelatin capsule comprising medium chain triglycerides (MCT) oil disposed within the pouch, and wherein the capsule is operable to partially dissolve in contact with saliva when used orally to release the MCT oil, and wherein the pouch is further operable to release the granulate mixture and the MCT oil over time.
12. The oral nicotine product of claim 11 , wherein the MCT oil is operable to function as an anti-stick agent to substantially prevent the fiber paper of the pouch from sticking.
13. The oral nicotine product of claim 11 , wherein the gelatin capsule further comprises a natural anesthetic.
14. The oral nicotine product of claim 11 , wherein the gelatin capsule further comprises terpenes or essential oils.
15. The oral nicotine product of claim 11 , wherein the nicotine is derived from tobacco.
16. The oral nicotine product of claim 11 , wherein nicotine is derived synthetically.
17. The oral nicotine product of claim 11 , wherein the gelatin capsule is a spherical 5 mm gelatin capsule.
18. The oral nicotine product of claim 11 , wherein the gelatin capsule further comprises flavoring agents.
19. The oral nicotine product of claim 11 , wherein the MCT oil is operable to reduce unpleasant tastes produced by the nicotine.
20. An oral nicotine product, comprising:
a pouch comprising rayon with polyester and an acrylic binder;
a granulate mixture disposed within the pouch, wherein the granulated mixture comprises nicotine, microcrystalline cellulose, and b-cyclodextrin; and
a gelatin capsule comprising medium chain triglycerides (MCT) oil, essential oils, and terpenes, and natural anesthetics disposed within the pouch, wherein the capsule releases the MCT oil over time when held in a mouth, and wherein the pouch is operable to release the granulate mixture and the MCT oil over time into the mouth when used orally.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/700,401 US20230292827A1 (en) | 2022-03-21 | 2022-03-21 | Nicotine pouch with capsule having mct oil |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/700,401 US20230292827A1 (en) | 2022-03-21 | 2022-03-21 | Nicotine pouch with capsule having mct oil |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230292827A1 true US20230292827A1 (en) | 2023-09-21 |
Family
ID=88066072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/700,401 Pending US20230292827A1 (en) | 2022-03-21 | 2022-03-21 | Nicotine pouch with capsule having mct oil |
Country Status (1)
Country | Link |
---|---|
US (1) | US20230292827A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160157515A1 (en) * | 2014-12-05 | 2016-06-09 | R.J. Reynolds Tobacco Company | Smokeless tobacco pouch |
US20220312826A1 (en) * | 2021-04-06 | 2022-10-06 | Altria Client Services Llc | Liquid mixtures of triglyceride and liquid nicotine |
-
2022
- 2022-03-21 US US17/700,401 patent/US20230292827A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160157515A1 (en) * | 2014-12-05 | 2016-06-09 | R.J. Reynolds Tobacco Company | Smokeless tobacco pouch |
US20220312826A1 (en) * | 2021-04-06 | 2022-10-06 | Altria Client Services Llc | Liquid mixtures of triglyceride and liquid nicotine |
Non-Patent Citations (2)
Title |
---|
Essential Oils Directory, https://www.aromaweb.com/essentialoils/index.php (Year: 2024) * |
Tirupathi S, Gopalakrishnan D, Deshkar S. Herbal topical anesthetics in dentistry: an exploratory review. J Dent Anesth Pain Med. 2022 Dec;22(6):419-426. doi: 10.17245/jdapm.2022.22.6.419. Epub 2022 Nov 24. PMID: 36601130; PMCID: PMC9763823. (Year: 2022) * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5283334B2 (en) | Composition material for transmucosal transmission | |
ES2929280T3 (en) | Nicotine bag product | |
ES2718634T3 (en) | A bag comprising a nicotine composition for transmucosal administration | |
JP6117287B2 (en) | Smokeless tobacco products | |
US5824334A (en) | Tobacco substitute | |
ES2595158T3 (en) | Sachet containing nicotine in the form of free salt | |
KR101831463B1 (en) | Inhibition of sensory irritation during consumption of non-smokeable tobacco products | |
JP2602043B2 (en) | Oral administration capsule containing nicotine-containing fluid medium | |
WO1991001656A1 (en) | Means for use as an aid to stop smoking or for use in non-smoking areas | |
BR112012024364A2 (en) | inhibition of undesirable sensory effects by the camphor compound. | |
JP2011229481A (en) | Filter for cigarette and cigarette with filter | |
US20230292827A1 (en) | Nicotine pouch with capsule having mct oil | |
ES2247598T3 (en) | TOBACCO SUBSTITUTE. | |
Christen et al. | The smokeless tobacco ‘time bomb’ | |
RU2819587C2 (en) | Nicotine sachet product | |
CN1741791B (en) | A composition material for transmucosal delivery | |
RU2818242C2 (en) | Product in form of sachet with liquid composition of flavouring additive | |
WO2024050253A2 (en) | User-adaptive oral pouch and method of use | |
US20120042892A1 (en) | Method of manufacture and product for removing tobacco odor from breath | |
CN118489933A (en) | Buccal nicotine product containing explosive beads and preparation method thereof | |
WO2024160586A1 (en) | Oral product for delivery of an active ingredient | |
KR200345312Y1 (en) | A cigarette-shaped gum inserted in fragrance-capsule | |
FR2794981A1 (en) | Anti-smoking pillow has velvet padding enclosed in envelope and containing micro-capsules of essential oils |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: LUCY GOODS, INC., NEVADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TANAKIT, RYAN;RENTELN, DAVID;HAMDOUCHE, SAMY;SIGNING DATES FROM 20240326 TO 20240328;REEL/FRAME:067772/0352 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |